Symbols / MAIA
MAIA Chart
About
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 84.25M |
| Enterprise Value | 78.73M | Income | -22.34M | Sales | — |
| Book/sh | 0.00 | Cash/sh | 0.29 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | — | Forward P/E | -3.30 | PEG | — |
| P/S | — | P/B | 2275.00 | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | 1.10 |
| Current Ratio | 1.18 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.74 | EPS next Y | -0.69 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-07 16:00 | ROA | -148.38% |
| ROE | -26.91% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 37.03M |
| Shs Float | 32.15M | Short Float | 6.10% | Short Ratio | 1.64 |
| Short Interest | — | 52W High | 3.19 | 52W Low | 0.87 |
| Beta | -0.04 | Avg Volume | 939.10K | Volume | 564.75K |
| Target Price | $12.13 | Recom | None | Prev Close | $2.42 |
| Price | $2.27 | Change | -5.99% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$12.14
Mean price target
2. Current target
$2.28
Latest analyst target
3. DCF / Fair value
$-3.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.28
Low
$10.27
High
$14.00
Mean
$12.14
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-02-21 | init | Noble Capital Markets | — → Outperform | $14 |
- New lung cancer drug targets 50,000 patients with no standard care - Stock Titan ue, 24 Feb 2026 13
- Maia 200 Gives Microsoft Stock (NASDAQ:MSFT) a Boost With Goldman Sachs, But Nowhere Else - TipRanks Mon, 23 Feb 2026 18
- Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Nigeria hu, 04 Dec 2025 08
- $MAIA stock is up 12% today. Here's what we see in our data. - Quiver Quantitative hu, 11 Dec 2025 08
- 2 Stocks to Buy as Microsoft Announces Its New Maia 200 AI Chip (Hint, Neither Is MSFT) - Barchart.com Wed, 28 Jan 2026 08
- MAIA Biotechnology Advances Ateganosine Cancer Treatment - GlobeNewswire ue, 20 Jan 2026 08
- MAIA Biotechnology Announces $1.51 Million Private Placement - Yahoo Finance ue, 16 Dec 2025 08
- MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program - TipRanks ue, 24 Feb 2026 14
- Goldman Sachs reiterates Buy on Microsoft stock after Maia chip progress - Investing.com Mon, 23 Feb 2026 12
- MAIA Biotechnology (NYSE American: MAIA) Reports 38% Response in THIO-101 NSCLC Study in Romania - Stock Titan hu, 20 Nov 2025 08
- MAIA Biotechnology, Inc. Announces Private Placement of Common Stock and Warrants to Accredited Investors - Quiver Quantitative Mon, 13 Oct 2025 07
- As Microsoft Launches Its New Maia 200 AI Accelerator, Should You Buy MSFT Stock? - Yahoo Finance Wed, 28 Jan 2026 08
- MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - GlobeNewswire Mon, 01 Dec 2025 08
- MAIA Biotechnology (NYSE American: MAIA) details 30-month survival in THIO-101 NSCLC - Stock Titan hu, 23 Oct 2025 07
- Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks ue, 09 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 40849 | 49999 | — | Purchase at price 1.22 per share. | CHAOUKI STEVEN M | Director | — | 2025-12-22 00:00:00 | D |
| 1 | 57189 | 69999 | — | Purchase at price 1.22 per share. | SMITH STAN V | Director | — | 2025-12-22 00:00:00 | I |
| 2 | 81699 | 100000 | — | Purchase at price 1.22 per share. | LOUIE NGAR YEE | Director | — | 2025-12-22 00:00:00 | D |
| 3 | 13740 | 16441 | — | Purchase at price 1.19 - 1.20 per share. | SMITH STAN V | Director | — | 2025-12-05 00:00:00 | I |
| 4 | 38145 | 41846 | — | Purchase at price 1.08 - 1.11 per share. | LUPUT CRISTIAN | Director | — | 2025-11-28 00:00:00 | D |
| 5 | 72000 | 79849 | — | Purchase at price 1.05 - 1.14 per share. | VITOC VLAD | Chief Executive Officer | — | 2025-11-28 00:00:00 | D |
| 6 | 72000 | 79849 | — | Purchase at price 1.05 - 1.14 per share. | VITOC VLAD | Chief Executive Officer | — | 2025-11-28 00:00:00 | D |
| 7 | 15000 | 15582 | — | Purchase at price 1.04 per share. | SMITH STAN V | Director | — | 2025-11-26 00:00:00 | I |
| 8 | 10000 | 9785 | — | Purchase at price 0.98 per share. | LUPUT CRISTIAN | Director | — | 2025-11-25 00:00:00 | D |
| 9 | 25000 | 24600 | — | Purchase at price 0.98 - 0.99 per share. | SMITH STAN V | Director | — | 2025-11-25 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -16.56M | -19.97M | -15.86M | -7.74M |
| TotalUnusualItems | -6.70M | 205.13K | 98.39K | -4.01M |
| TotalUnusualItemsExcludingGoodwill | -6.70M | 205.13K | 98.39K | -4.01M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -23.25M | -19.77M | -15.77M | -12.50M |
| EBITDA | -23.25M | -19.77M | -15.76M | -11.75M |
| EBIT | -23.25M | -19.77M | -15.76M | -11.75M |
| NetInterestIncome | 318.31K | 27.63K | -5.10K | -825.53K |
| InterestExpense | 57.00 | 6.86K | 6.97K | 827.54K |
| InterestIncome | 318.37K | 34.49K | 1.87K | 2.01K |
| NormalizedIncome | -16.56M | -19.98M | -15.87M | -8.49M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -23.25M | -19.77M | -15.77M | -12.50M |
| TotalExpenses | 16.88M | 20.01M | 15.86M | 7.74M |
| TotalOperatingIncomeAsReported | -16.96M | -20.18M | -16.18M | -7.79M |
| DilutedAverageShares | 22.20M | 13.26M | 9.28M | 10.64M |
| BasicAverageShares | 22.20M | 13.26M | 9.28M | 10.64M |
| DilutedEPS | -1.05 | -1.49 | -1.75 | -1.18 |
| BasicEPS | -1.05 | -1.49 | -1.75 | -1.18 |
| DilutedNIAvailtoComStockholders | -23.25M | -19.77M | -16.22M | -12.50M |
| NetIncomeCommonStockholders | -23.25M | -19.77M | -16.22M | -12.50M |
| OtherunderPreferredStockDividend | 0.00 | 450.58K | 0.00 | |
| NetIncome | -23.25M | -19.77M | -15.77M | -12.50M |
| MinorityInterests | 0.00 | 74.33K | ||
| NetIncomeIncludingNoncontrollingInterests | -23.25M | -19.77M | -15.77M | -12.58M |
| NetIncomeContinuousOperations | -23.25M | -19.77M | -15.77M | -12.58M |
| PretaxIncome | -23.25M | -19.77M | -15.77M | -12.58M |
| OtherIncomeExpense | -6.70M | 205.13K | 98.39K | -4.01M |
| SpecialIncomeCharges | 0.00 | -2.26M | ||
| OtherSpecialCharges | 2.26M | |||
| GainOnSaleOfSecurity | -6.70M | 205.13K | 98.39K | -1.75M |
| NetNonOperatingInterestIncomeExpense | 318.31K | 27.63K | -5.10K | -825.53K |
| InterestExpenseNonOperating | 57.00 | 6.86K | 6.97K | 827.54K |
| InterestIncomeNonOperating | 318.37K | 34.49K | 1.87K | 2.01K |
| OperatingIncome | -16.88M | -20.01M | -15.86M | -7.74M |
| OperatingExpense | 16.88M | 20.01M | 15.86M | 7.74M |
| OtherOperatingExpenses | -79.95K | -176.72K | 785.74K | |
| ResearchAndDevelopment | 10.01M | 11.11M | 8.93M | 3.45M |
| SellingGeneralAndAdministration | 6.95M | 9.07M | 6.14M | 4.29M |
| GeneralAndAdministrativeExpense | 6.95M | 9.07M | 6.14M | 4.29M |
| OtherGandA | 6.95M | 9.07M | 6.14M | 4.29M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 26.16M | 16.99M | 10.96M | 10.22M |
| ShareIssued | 26.16M | 16.99M | 10.96M | 10.22M |
| TangibleBookValue | 3.63M | 477.51K | 8.51M | 9.18M |
| InvestedCapital | 3.63M | 477.51K | 8.51M | 9.18M |
| WorkingCapital | 6.32M | 2.63M | 8.54M | 8.53M |
| NetTangibleAssets | 3.63M | 477.51K | 8.51M | 9.18M |
| CommonStockEquity | 3.63M | 477.51K | 8.51M | 9.18M |
| TotalCapitalization | 3.63M | 477.51K | 8.51M | 9.18M |
| TotalEquityGrossMinorityInterest | 3.63M | 477.51K | 8.51M | 9.18M |
| MinorityInterest | 0.00 | |||
| StockholdersEquity | 3.63M | 477.51K | 8.51M | 9.18M |
| GainsLossesNotAffectingRetainedEarnings | -30.61K | -16.26K | -15.97K | 0.00 |
| OtherEquityAdjustments | -30.61K | -16.26K | -15.97K | |
| RetainedEarnings | -87.23M | -63.98M | -44.21M | -28.44M |
| AdditionalPaidInCapital | 90.90M | 64.47M | 52.73M | 37.62M |
| CapitalStock | 2.62K | 1.70K | 1.10K | 758.00 |
| CommonStock | 2.62K | 1.70K | 1.10K | 758.00 |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 6.52M | 7.09M | 3.51M | 2.15M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.69M | 2.15M | 245.34K | 0.00 |
| DerivativeProductLiabilities | 2.69M | 2.15M | 245.34K | 0.00 |
| CurrentLiabilities | 3.83M | 4.94M | 3.27M | 2.15M |
| CurrentDeferredLiabilities | 0.00 | 111.27K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 941.10K | 1.61M | 1.09M | 384.75K |
| PayablesAndAccruedExpenses | 2.89M | 3.33M | 2.17M | 1.65M |
| CurrentAccruedExpenses | 1.38M | 1.69M | 1.01M | 689.57K |
| InterestPayable | 0.00 | |||
| Payables | 1.51M | 1.64M | 1.17M | 960.40K |
| DuetoRelatedPartiesCurrent | 0.00 | |||
| AccountsPayable | 1.51M | 1.64M | 1.17M | 960.40K |
| TotalAssets | 10.16M | 7.57M | 12.02M | 11.33M |
| TotalNonCurrentAssets | 2.80K | 2.80K | 214.00K | 654.70K |
| OtherNonCurrentAssets | 2.80K | 2.80K | 2.80K | 3.12K |
| NonCurrentDeferredAssets | 0.00 | 211.20K | 651.58K | |
| CurrentAssets | 10.15M | 7.56M | 11.81M | 10.67M |
| OtherCurrentAssets | 473.83K | 268.68K | 554.32K | 54.54K |
| PrepaidAssets | 98.20K | |||
| Receivables | 77.35K | 144.68K | 302.79K | 43.67K |
| OtherReceivables | 77.35K | 144.68K | 302.79K | 43.67K |
| CashCashEquivalentsAndShortTermInvestments | 9.60M | 7.15M | 10.95M | 10.57M |
| CashAndCashEquivalents | 9.60M | 7.15M | 10.95M | 10.57M |
| CashFinancial | 9.60M | 7.15M | 10.95M | 10.57M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -15.70M | -13.07M | -12.10M | -4.12M |
| RepaymentOfDebt | 0.00 | -367.00 | ||
| IssuanceOfDebt | 0.00 | 7.43M | ||
| IssuanceOfCapitalStock | 18.75M | 11.42M | 13.97M | 5.74M |
| EndCashPosition | 9.60M | 7.15M | 10.95M | 10.57M |
| BeginningCashPosition | 7.15M | 10.95M | 10.57M | 663.46K |
| EffectOfExchangeRateChanges | -21.55K | -117.00 | -4.43K | 0.00 |
| ChangesInCash | 2.47M | -3.80M | 381.06K | 9.91M |
| FinancingCashFlow | 18.18M | 9.27M | 12.48M | 14.03M |
| CashFlowFromContinuingFinancingActivities | 18.18M | 9.27M | 12.48M | 14.03M |
| NetOtherFinancingCharges | -795.26K | -2.15M | -1.97M | 322.00K |
| ProceedsFromStockOptionExercised | 217.16K | 1.43K | 469.40K | 538.42K |
| NetCommonStockIssuance | 18.75M | 11.42M | 13.97M | 5.74M |
| CommonStockIssuance | 18.75M | 11.42M | 13.97M | 5.74M |
| NetIssuancePaymentsOfDebt | 0.00 | 7.43M | ||
| NetLongTermDebtIssuance | 0.00 | 7.43M | ||
| LongTermDebtPayments | 0.00 | -367.00 | ||
| LongTermDebtIssuance | 0.00 | 7.43M | ||
| OperatingCashFlow | -15.70M | -13.07M | -12.10M | -4.12M |
| CashFlowFromContinuingOperatingActivities | -15.70M | -13.07M | -12.10M | -4.12M |
| ChangeInWorkingCapital | -1.24M | 3.09M | 352.78K | 1.13M |
| ChangeInOtherWorkingCapital | 440.38K | -651.58K | ||
| ChangeInOtherCurrentAssets | 0.00 | 322.00 | -3.12K | |
| ChangeInPayablesAndAccruedExpense | -1.10M | 2.64M | 1.13M | 1.80M |
| ChangeInAccruedExpense | -979.79K | 2.17M | 915.74K | 997.13K |
| ChangeInPayable | -118.83K | 471.90K | 211.35K | 798.48K |
| ChangeInAccountPayable | -118.83K | 471.90K | 211.35K | 805.52K |
| ChangeInPrepaidAssets | -195.94K | 285.83K | -505.23K | -15.15K |
| ChangeInReceivables | 56.80K | 158.41K | -269.39K | 0.00 |
| OtherNonCashItems | 179.49K | 731.66K | 1.10M | 596.95K |
| StockBasedCompensation | 1.91M | 3.09M | 2.32M | 2.72M |
| OperatingGainsLosses | 6.70M | -205.13K | -98.39K | 4.01M |
| GainLossOnInvestmentSecurities | 6.70M | -205.13K | -98.39K | 1.75M |
| NetIncomeFromContinuingOperations | -23.25M | -19.77M | -15.77M | -12.58M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for MAIA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|